Your browser doesn't support javascript.
loading
DLBCL-associated NOTCH2 mutations escape ubiquitin-dependent degradation and promote chemoresistance.
Zhou, Nan; Choi, Jaewoo; Grothusen, Grant; Kim, Bang-Jin; Ren, Diqiu; Cao, Zhendong; Liu, Yiman; Li, Qinglan; Inamdar, Arati; Beer, Thomas; Tang, Hsin-Yao; Perkey, Eric; Maillard, Ivan; Bonasio, Roberto; Shi, Junwei; Ruella, Marco; Wan, Liling; Busino, Luca.
Affiliation
  • Zhou N; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Choi J; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Grothusen G; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Kim BJ; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Ren D; Department of Surgery, Columbia University Irving Medical Center, New York, NY.
  • Cao Z; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Liu Y; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Li Q; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Inamdar A; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Beer T; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Tang HY; Proteomics and Metabolomics Facility, The Wistar Institute, Philadelphia, PA.
  • Perkey E; Proteomics and Metabolomics Facility, The Wistar Institute, Philadelphia, PA.
  • Maillard I; Division of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Bonasio R; Division of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Shi J; Epigenetics Institute and Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Ruella M; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Wan L; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA.
  • Busino L; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Blood ; 142(11): 973-988, 2023 09 14.
Article in En | MEDLINE | ID: mdl-37235754

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Drug Resistance, Neoplasm Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Drug Resistance, Neoplasm Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Year: 2023 Document type: Article